Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesions

BACKGROUND: Next-generation sequencing (NGS) has shown that recurrent/metastatic breast cancer lesions may have additional genetic changes compared with the primary tumor. These additional changes may be related to tumor progression and/or drug resistance. However, breast cancer-targeted NGS is not...

Descripción completa

Detalles Bibliográficos
Autores principales: Akahane, Toshiaki, Kanomata, Naoki, Harada, Oi, Yamashita, Tetsumasa, Kurebayashi, Junichi, Tanimoto, Akihide, Moriya, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528467/
https://www.ncbi.nlm.nih.gov/pubmed/33004031
http://dx.doi.org/10.1186/s12885-020-07432-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528467/
https://www.ncbi.nlm.nih.gov/pubmed/33004031
http://dx.doi.org/10.1186/s12885-020-07432-w

Ejemplares similares